Trade Adaptive Biotechnologies Corporation - ADPT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 7.85 |
| Open | 7.71 |
| 1-Year Change | 201.17% |
| Day's Range | 7.71 - 7.92 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 7.87 | 0.06 | 0.77% | 7.81 | 7.94 | 7.64 |
| Apr 24, 2025 | 7.85 | 0.54 | 7.39% | 7.31 | 8.01 | 7.21 |
| Apr 23, 2025 | 7.33 | 0.08 | 1.10% | 7.25 | 7.83 | 7.25 |
| Apr 22, 2025 | 6.96 | 0.11 | 1.61% | 6.85 | 7.16 | 6.85 |
| Apr 21, 2025 | 6.80 | -0.29 | -4.09% | 7.09 | 7.37 | 6.75 |
| Apr 17, 2025 | 7.32 | -0.04 | -0.54% | 7.36 | 7.53 | 7.22 |
| Apr 16, 2025 | 7.47 | -0.08 | -1.06% | 7.55 | 7.66 | 7.28 |
| Apr 15, 2025 | 7.71 | 0.02 | 0.26% | 7.69 | 7.99 | 7.58 |
| Apr 14, 2025 | 7.71 | -0.28 | -3.50% | 7.99 | 8.06 | 7.62 |
| Apr 11, 2025 | 7.80 | 0.34 | 4.56% | 7.46 | 8.27 | 7.32 |
| Apr 10, 2025 | 7.70 | -0.20 | -2.53% | 7.90 | 8.09 | 7.49 |
| Apr 9, 2025 | 8.35 | 1.03 | 14.07% | 7.32 | 8.58 | 7.25 |
| Apr 8, 2025 | 7.65 | -0.20 | -2.55% | 7.85 | 8.44 | 7.42 |
| Apr 7, 2025 | 7.67 | 0.93 | 13.80% | 6.74 | 8.10 | 6.74 |
| Apr 4, 2025 | 7.46 | 0.46 | 6.57% | 7.00 | 7.60 | 6.65 |
| Apr 3, 2025 | 7.36 | 0.01 | 0.14% | 7.35 | 8.02 | 7.32 |
| Apr 2, 2025 | 7.93 | 0.64 | 8.78% | 7.29 | 8.01 | 7.26 |
| Apr 1, 2025 | 7.50 | 0.30 | 4.17% | 7.20 | 7.60 | 7.10 |
| Mar 31, 2025 | 7.40 | 0.16 | 2.21% | 7.24 | 7.66 | 7.08 |
| Mar 28, 2025 | 7.64 | -0.40 | -4.98% | 8.04 | 8.19 | 7.47 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Adaptive Biotechnologies Corporation Company profile
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corporation is a commercial-stage company. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform combines a suite of chemistry, biology and machine learning to generate clinical immunomics data to decode the adaptive immune system. Its commercial research products include immunoSEQ and immunoSEQ T-MAP. immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA). Its clonoSEQ diagnostic test detects and monitors the number of cancer cells that are present in a patient’s body during and after treatment, known as minimal residual disease (MRD). It uses its T cell receptor (TCR)-Antigen Map to develop research solutions and diagnostic products, such as immunoSEQ T-MAP and T-Detect. It also focuses on developing immune-mediated therapies in oncology and other disease areas.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Adaptive Biotechnologies Corp revenues increased 57% to $154.3M. Net loss increased 42% to $207.3M. Revenues reflect Sequencing revenue segment increase of 90% to $78.9M, Development revenue segment increase of 32% to $75.4M. Higher net loss reflects Research and development - Balancing increase of 19% to $128.3M (expense), General and administrative - Balancing increase of 47% to $59.7M (expense).
| Industry: | Bio Diagnostics & Testing |
1165 Eastlake Ave E
SEATTLE
WASHINGTON 98109
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com